Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, SciQuest Partner on Electronic Procurement; Sanger, Exelixis and Apoxis Are Among First Customers

NEW YORK (GenomeWeb News) - Invitrogen and SciQuest have signed a partnership to provide an electronic procurement software platform to Invitrogen's customers, the companies said today.
 
SciQuest, based in Research Triangle Park, NC, specializes in on-demand supply management and automated procurement solutions.
 
The partnership will enable customers to use SciQuest's software to electronically purchase products from Invitrogen along with other vendors with a single purchase order, the companies said.
 
Michael Stapleton, Invitrogen’s vice president of e-business and marketing, said the partnership helps create a "one-stop shop" for customers who "are under pressure to streamline their purchasing processes."
 
The companies also said they have signed "numerous" customers for the new offering, including the Wellcome Trust Sanger Institute, Exelixis, and Apoxis.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.